Get software! [General Sta­tis­tics]

posted by verstc – China, 2018-06-17 16:55 (2574 d 16:47 ago) – Posting: # 18910
Views: 6,405

Dear Helmut,

Thanks a lot for your reply.

It is clear to me for your explain.

I am wondering if there is a way to reduce the intra-subject CV. I think intra-subject CV is an inherent characteristic of a drug. is it right? If it not, does anyone can reduce it by any ways?

Thanks,

best,
Shawn


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,684 registered users;
44 visitors (0 registered, 44 guests [including 22 identified bots]).
Forum time: 09:43 CEST (Europe/Vienna)

In the field of observation,
chance favors only the mind that is prepared.    Louis Pasteur

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5